BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7428575)

  • 21. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

  • 23. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
    [No Abstract]   [Full Text] [Related]  

  • 25. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
    Deck KA; Gehrhardt A; Klein HO; Ludes H
    Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
    Bartelink AK; Lenders JW; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Tubercle; 1983 Jun; 64(2):125-8. PubMed ID: 6612792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoniazid-rifampin--induced fulminant liver disease in an infant.
    Bistritzer T; Barzilay Z; Jonas A
    J Pediatr; 1980 Sep; 97(3):480-2. PubMed ID: 6967966
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rifampicin and liver damage].
    Sehm G
    Prax Pneumol; 1970 Jul; 24(7):439-42. PubMed ID: 5433240
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic toxicity of antituberculous drugs in children.
    Allué X; Sanjurjo P; Fidalgo I; Bilbao F
    Helv Paediatr Acta; 1976 Dec; 31(4-5):381-7. PubMed ID: 1017983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 31. [The results of liver biopsies during rifampicin therapy (author's transl)].
    Kozma D; Lapis K; Tompa A
    Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 34. [Jaundice and cytolysis in patients receiving rifampicin and isoniazid at the same time].
    Morère P; Stain JP; Bourreille J; Nouvet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1110-9. PubMed ID: 5517158
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis induced by combination of rifampicin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5146732
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute liver insufficiency caused by rifampicin-isoniazid].
    Schalm SW; Taal BG
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1020-1. PubMed ID: 7402379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
    Marche J; Hugues FC; Graisely B; Marche C
    Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of hepatic function in patients treated with rifampicin].
    Morère P; Bourreille J; Matray F; Stain JP; Métayer P
    Rev Tuberc Pneumol (Paris); 1970; 34(3):403-14. PubMed ID: 5510435
    [No Abstract]   [Full Text] [Related]  

  • 39. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin and icterus. Cases in humans].
    Graisely B; Emery JP; Hugues FC; Marche J
    Therapie; 1971; 26(4):655-69. PubMed ID: 5119120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.